Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MONTELUKAST for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 21 adverse event reports in the FDA FAERS database where MONTELUKAST was used for Psoriasis.

Most Reported Side Effects for MONTELUKAST

Side Effect Reports % Deaths Hosp.
Asthma 8,372 31.0% 208 3,766
Dyspnoea 6,354 23.6% 88 3,164
Wheezing 5,159 19.1% 52 2,588
Drug ineffective 3,539 13.1% 142 1,358
Cough 3,475 12.9% 25 1,633
Therapeutic product effect incomplete 3,352 12.4% 55 1,765
Anxiety 2,994 11.1% 72 666
Loss of personal independence in daily activities 2,736 10.1% 42 1,539
Sleep disorder due to a general medical condition 2,101 7.8% 46 1,156
Obstructive airways disorder 2,073 7.7% 45 1,209
Pneumonia 2,071 7.7% 78 890
Headache 2,047 7.6% 132 642
Depression 2,041 7.6% 37 419
Fatigue 1,959 7.3% 131 604
Drug hypersensitivity 1,792 6.6% 122 313

Other Indications for MONTELUKAST

Product used for unknown indication (11,960) Asthma (7,298) Hypersensitivity (852) Multiple allergies (518) Chronic spontaneous urticaria (416) Rhinitis allergic (344) Ill-defined disorder (222) Seasonal allergy (220) Cough (202) Urticaria (157)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

MONTELUKAST Full Profile All Psoriasis Drugs MONTELUKAST Demographics MONTELUKAST Timeline